Neue Suche | Kongressdetail
Druckansicht
 
 

Interstitial Lung Disease Drug Development Summit

Evvnt Promotion / evvnt
-
27.04.2021 - 29.04.2021  Online
Time: 09:00 - 15:00
 
Kongressthemen
With the entire world's attention focused firmly on pulmonary fibrosis in the wake of COVID19 and the landmark INBUILD study dramatically overhauling the ILD drug development landscape, biopharma are finally on the cusp of developing and disseminating life-changing therapeutics for patients suffering with interstitial lung disease.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Ahmad Nabhan, Postdoctoral Scholar, Genentech, Christina Wenglen, Head of Research, AnaMar, Craig Conoscenti, Medical Expert ILD Respiratory Clinical Development and Medical Affairs, Boehringer Ingelheim and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/729096-2?pid=4832
Herr Customer Service
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Conference + Workshops Day - Industry: $2799.0, Conference Only - Industry: $1999.0, Workshop Day - Industry: $899.0, Conference + Workshops Day - Academic: $1899.0, Conference Only - Academic: $1299.0, Workshops Day - Academic: $699.0
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteCharité International AcademyAMREF - African Medical and Research FoundationAlumni Club Medizinische Universität WienAnästhesie in Entwicklungsländern e. V.Helix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichisches Rotes Kreuz